Is ONCT a good investment?
As of 2025-03-17, the Fair Value of Oncternal Therapeutics Inc (ONCT) is -58.40 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.53 USD, the upside of Oncternal Therapeutics Inc is -11,190.68%. This means that ONCT is not a good investment.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -34.19 | -17.23 | -31.33 | -44.17 | -39.48 | -33.28 |
| YoY growth | 11.01% | 49.62% | -81.90% | -40.97% | 10.62% | -10.33% |
| Market Cap (mil) | 1.56 |
| P/E | |
| Forward P/E |
| EPS | -11.68 |
| Avg earnings growth rate | -10.33% |
| TTM earnings | -34.58 |